Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
Clinical trial NCT07551505 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07551505
- Sponsor
- Bisirna Therapeutics (Suzhou) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2027-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.